The Lancet Oncology · 2016 · 778 citations · 24 references
MedicineOncologyPharmacologyCancer ImmunologyCancer PharmacologyImmunotherapyCancer ImmunotherapyPancreatic CancerTargeted Cancer TherapyTargeted TherapyTumor Microenvironment ModulationTumor-associated MacrophagesAnti-tumor Macrophage ResponsesBorderline Resectable DiseaseC-c Chemokine Receptor 2 SignalingCancer-associated MacrophagesMacrophage-targeted TherapeuticsPancreatic Cancer PharmacotherapyPancreatic Cancer Systemic Therapy
24
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations
Medicine, Oncology, Pharmacology +13
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology · 2015 · 5.3K citations · Full text